Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 52
2020 80
2021 87
2022 98
2023 85
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Results by year

Filters applied: . Clear all
Page 1
Treatment Guidelines in Vasculitis.
Kermani TA, Warrington KJ, Dua AB. Kermani TA, et al. Rheum Dis Clin North Am. 2022 Aug;48(3):705-724. doi: 10.1016/j.rdc.2022.03.006. Epub 2022 Jul 5. Rheum Dis Clin North Am. 2022. PMID: 35953232 Review.
The American College of Rheumatology/Vasculitis Foundation recently published guidelines on the management of several forms of primary systemic vasculitides. In this review, the recommendations for giant cell arteritis, Takayasu arteritis, polyarteritis nodos …
The American College of Rheumatology/Vasculitis Foundation recently published guidelines on the management of several forms of primary syste …
Large-vessel vasculitis.
Pugh D, Karabayas M, Basu N, Cid MC, Goel R, Goodyear CS, Grayson PC, McAdoo SP, Mason JC, Owen C, Weyand CM, Youngstein T, Dhaun N. Pugh D, et al. Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5. Nat Rev Dis Primers. 2022. PMID: 34992251 Free PMC article. Review.
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches and is the most common primary vasculitis in adults. LVV comprises two distinct conditions, giant cell arteritis and Takayasu arteritis, although the phenotypic spectr …
Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches and is the most common primary vasculitis in adu …
Giant Cell Arteritis.
Younger DS. Younger DS. Neurol Clin. 2019 May;37(2):335-344. doi: 10.1016/j.ncl.2019.01.008. Epub 2019 Mar 16. Neurol Clin. 2019. PMID: 30952412 Review.
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising overlapping phenotypes of cranial arteritis and extracranial GCA. ...
"Giant cell arteritis (GCA) is a chronic, idiopathic, granulomatous vasculitis of medium and large arteries comprising …
Giant cell arteritis.
Pepper K. Pepper K. Postgrad Med. 2023 Jan;135(sup1):22-32. doi: 10.1080/00325481.2023.2190288. Epub 2023 Apr 6. Postgrad Med. 2023. PMID: 37021621 Review.
Giant cell arteritis (GCA, also known as temporal arteritis) is classified as a vasculitis of large and medium sized vessels and can involve the cranial vessels as well as the aorta and great vessels. ...
Giant cell arteritis (GCA, also known as temporal arteritis) is classified as a vasculitis of large and medium sized ve …
An update on polymyalgia rheumatica.
Lundberg IE, Sharma A, Turesson C, Mohammad AJ. Lundberg IE, et al. J Intern Med. 2022 Nov;292(5):717-732. doi: 10.1111/joim.13525. Epub 2022 Jun 11. J Intern Med. 2022. PMID: 35612524 Free PMC article. Review.
This is associated with high rates of GC-related comorbidities, such as diabetes and osteoporosis, and there are limited data on the use of disease-modifying antirheumatic drugs and biologics as GC sparing agents. Finally, PMR is associated with giant cell arteri …
This is associated with high rates of GC-related comorbidities, such as diabetes and osteoporosis, and there are limited data on the use of …
Medium- and Large-Vessel Vasculitis.
Saadoun D, Vautier M, Cacoub P. Saadoun D, et al. Circulation. 2021 Jan 19;143(3):267-282. doi: 10.1161/CIRCULATIONAHA.120.046657. Epub 2021 Jan 19. Circulation. 2021. PMID: 33464968 Review.
The term "large vessel" relates to the aorta and its major branches; "medium vessel" refers to the main visceral arteries and veins and their initial branches. The most common causes of large-vessel vasculitis are giant cell arteritis and Takayasu arteritis, …
The term "large vessel" relates to the aorta and its major branches; "medium vessel" refers to the main visceral arteries and veins and thei …
A new era for giant cell arteritis.
Lyons HS, Quick V, Sinclair AJ, Nagaraju S, Mollan SP. Lyons HS, et al. Eye (Lond). 2020 Jun;34(6):1013-1026. doi: 10.1038/s41433-019-0608-7. Epub 2019 Oct 3. Eye (Lond). 2020. PMID: 31582795 Free PMC article. Review.
The landscape of the investigation and management of giant cell arteritis (GCA) is advancing. In this review we will outline the recent advances by searching the current English literature for relevant articles using key words of giant cell a …
The landscape of the investigation and management of giant cell arteritis (GCA) is advancing. In this review we will ou …
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.
Camellino D, Giusti A, Girasole G, Bianchi G, Dejaco C. Camellino D, et al. Drugs Aging. 2019 Nov;36(11):1015-1026. doi: 10.1007/s40266-019-00705-5. Drugs Aging. 2019. PMID: 31493201 Review.
Polymyalgia rheumatica can occur independently or in association with giant cell arteritis, which is the most common form of primary vasculitis. ...
Polymyalgia rheumatica can occur independently or in association with giant cell arteritis, which is the most common fo …
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA. Hellmich B, et al. Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3. Ann Rheum Dis. 2020. PMID: 31270110
High dose glucocorticoid therapy (40-60 mg/day prednisone-equivalent) should be initiated immediately for induction of remission in active giant cell arteritis (GCA) or Takayasu arteritis (TAK). We recommend adjunctive therapy in selected patients with GCA (r …
High dose glucocorticoid therapy (40-60 mg/day prednisone-equivalent) should be initiated immediately for induction of remission in active …
Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets.
Nepal D, Putman M, Unizony S. Nepal D, et al. Rheum Dis Clin North Am. 2023 Aug;49(3):505-521. doi: 10.1016/j.rdc.2023.03.005. Epub 2023 Apr 18. Rheum Dis Clin North Am. 2023. PMID: 37331730 Review.
Prolonged glucocorticoid tapers have been the standard of care for giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), but recent advancements have improved outcomes for patients with GCA while reducing glucocorticoid-related toxicities. ...
Prolonged glucocorticoid tapers have been the standard of care for giant cell arteritis (GCA) and polymyalgia rheumatic …
371 results